Literature DB >> 7938127

Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers.

S E Lukas1, M Sholar, E Kouri, H Fukuzako, J H Mendelson.   

Abstract

The reasons why individuals use this combination are not entirely clear, however, it has been speculated that marihuana may potentiate cocaine's subjective effects. Five male recreational drug users provided informed consent and volunteered to participate in this study. Each subject participated on 3 different days, separated by at least 1 week. Subjects sat in an isolated chamber and were prepared with electrocardiographic (ECG) electrodes for heart rate monitoring and an IV catheter for blood withdrawal. After adapting to the experimental chamber, they smoked a marihuana cigarette containing either 0.004% (placebo), 1.24%, or 2.64% delta 9-tetrahydrocannabinol (THC). Thirty minutes later they received an intranasal dose of 0.9 mg/kg cocaine. On subsequent visits, the marihuana dose was varied on a random basis. Subjects continuously reported changes in their mood state via an instrumental joystick device and filled out visual analog scales. Marihuana-induced tachycardia was increased even more after cocaine. The duration of all marihuana- and cocaine-related positive subjective effects was unchanged when both drugs were given, but marihuana pretreatment significantly reduced the latency to cocaine effects, from 1.87 to 0.53 min, and decreased the duration of dysphoric or bad effects, from 2.1 to 0.5 min. Peak plasma cocaine levels were 122.8 +/- 26.6 ng/ml after placebo marihuana, but pretreatment with the high-dose marihuana resulted in a significant increase in peak cocaine levels (233.8 +/- 19.2 ng/ml) and the apparent bioavailability as determined by area under the curve (AUC) analysis. We conclude that marihuana-induced vasodilation of the nasal mucosa attenuates the vasoconstrictive effects of cocaine and thus increases its absorption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7938127     DOI: 10.1016/0091-3057(94)90338-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

Review 1.  Recreational drug misuse: issues for the cardiologist.

Authors:  A Ghuran; J Nolan
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

2.  An MR-compatible device for delivering smoked marijuana during functional imaging.

Authors:  Blaise deB Frederick; Kimberly P Lindsey; Lisa D Nickerson; Elizabeth T Ryan; Scott E Lukas
Journal:  Pharmacol Biochem Behav       Date:  2007-04-13       Impact factor: 3.533

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

4.  Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders.

Authors:  Lesia M Ruglass; Alina Shevorykin; Christina Brezing; Mei-Chen Hu; Denise A Hien
Journal:  J Subst Abuse Treat       Date:  2017-06-28

Review 5.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

6.  Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers.

Authors:  S E Lukas; M Sholar; L H Lundahl; X Lamas; E Kouri; J D Wines; L Kragie; J H Mendelson
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

7.  Stress system changes associated with marijuana dependence may increase craving for alcohol and cocaine.

Authors:  Helen C Fox; Keri L Tuit; Rajita Sinha
Journal:  Hum Psychopharmacol       Date:  2012-12-28       Impact factor: 1.672

8.  Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys.

Authors:  X Lamas; S S Negus; E Hall; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

9.  Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.

Authors:  David R Maguire; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2014-09-05       Impact factor: 4.030

10.  Cannabinoid Modulation of Food-Cocaine Choice in Male Rhesus Monkeys.

Authors:  William S John; Thomas J Martin; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2020-01-15       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.